Mutational Analysis as a Prognostic and Predictive Marker of Cardiovascular (CVD) Disease in Patients With Myelodysplasia

NCT04110925 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

MDS
Cardiovascular Diseases
Inflammation

Interventions

GENETIC: Genetic Mutations
OTHER: Inflammatory and lipid markers
OTHER: Computed Tomography (CT) of the heart

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]
[object Object]